VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $239,747,000 | -19.6% | 1,344,024 | +0.1% | 5.42% | -18.9% |
| Q2 2015 | $298,251,000 | +11.7% | 1,342,567 | -0.1% | 6.68% | +3.3% |
| Q1 2015 | $266,939,000 | +72.0% | 1,343,970 | +23.9% | 6.47% | +99.4% |
| Q4 2014 | $155,175,000 | -25.2% | 1,084,304 | -31.4% | 3.24% | -18.5% |
| Q3 2014 | $207,513,000 | +4.1% | 1,581,651 | +0.0% | 3.98% | -2.0% |
| Q2 2014 | $199,434,000 | +10.1% | 1,581,304 | +15.1% | 4.07% | -4.2% |
| Q1 2014 | $181,077,000 | +0.9% | 1,373,567 | -10.1% | 4.24% | -8.4% |
| Q4 2013 | $179,458,000 | +45.1% | 1,528,603 | +29.0% | 4.63% | +31.5% |
| Q3 2013 | $123,655,000 | +21.2% | 1,185,229 | 0.0% | 3.52% | +18.6% |
| Q2 2013 | $102,025,000 | – | 1,185,229 | – | 2.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |